| pubmed-article:20045791 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C1516213 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0024501 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0178602 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0055982 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C1136535 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0205345 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C1317973 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0183683 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0344211 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C1521721 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0439228 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C1524063 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0522510 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C0721534 | lld:lifeskim |
| pubmed-article:20045791 | lifeskim:mentions | umls-concept:C1171411 | lld:lifeskim |
| pubmed-article:20045791 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:20045791 | pubmed:dateCreated | 2010-1-4 | lld:pubmed |
| pubmed-article:20045791 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:abstractText | In several commonly used regimens, chemotherapy doses are split across different days of the cycle. We aimed to determine the feasibility of growth factor support with once-per-cycle pegfilgrastim in this setting. | lld:pubmed |
| pubmed-article:20045791 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20045791 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20045791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20045791 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20045791 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:20045791 | pubmed:issn | 1699-3055 | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:CalvoJ JJJ | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:GridelliCesar... | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:FalconeAlfred... | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:SkacelTomasT | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:MattioliRodol... | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:CastellanosJa... | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:MansuttiMauro... | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:DuqueAntonioA | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:BaconPamP | lld:pubmed |
| pubmed-article:20045791 | pubmed:author | pubmed-author:LawrinsonSueS | lld:pubmed |
| pubmed-article:20045791 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20045791 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:20045791 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20045791 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20045791 | pubmed:pagination | 842-8 | lld:pubmed |
| pubmed-article:20045791 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:meshHeading | pubmed-meshheading:20045791... | lld:pubmed |
| pubmed-article:20045791 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:20045791 | pubmed:articleTitle | Use of pegfilgrastim support on day 9 to maintain relative dose intensity of chemotherapy in breast cancer patients receiving a day 1 and 8 CMF regimen. | lld:pubmed |
| pubmed-article:20045791 | pubmed:affiliation | U.O. di Oncologia, Ospedale S. Croce, Fano, Italy. | lld:pubmed |
| pubmed-article:20045791 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20045791 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:20045791 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:20045791 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
